Pliant Therapeutics Inc. Made Headway
Mon, Jan 23, 2023 at 07:01 PM
Pliant Therapeutics Inc. (PLRX:NASDAQ) rocketted at $30.28, representing a gain of 34.5%. On Mon, Jan 23, 2023, PLRX:NASDAQ hit a New 2-Week High of $30.28. The stock got featured on our News Catalysts scanner on Mon, Jan 23, 2023 at 04:55 PM in the 'PUBLIC OFFERING' category. From Mon, Jan 09, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days
About Pliant Therapeutics Inc. (PLRX:NASDAQ)
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis.
Top 10 Gainers:
- Intelligent Bio Solutions Inc Com (INBS:NASDAQ), 281.48%
- Helbiz Inc. (HLBZ:NASDAQ), 109.13%
- Verb Technology Company, Inc. (VERB:NASDAQ), 69.65%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 53.23%
- Inspira Technologies Oxy B.H.N. Ltd. (IINN:NASDAQ), 50.81%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 50.64%
- Genius Group Limited (GNS:NYSEMKT), 45.37%
- Pliant Therapeutics Inc. (PLRX:NASDAQ), 34.52%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 33.49%
- CN Energy Group Inc. (CNEY:NASDAQ), 30.45%